跳至主要内容
临床试验/NL-OMON50843
NL-OMON50843招募中不适用

Defining the Diagnostic Value of High-Pitch CCTA and Dynamic CT Perfusion in patients with prior PCI for the Diagnosis of Myocardial Ischemia as Defined by Invasive Flow and Pressure Indices - The PACIFIC-III trial - The PACIFIC-III trial

Vrije Universiteit Medisch Centrum0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - History of PCI for stable CAD
  • - Referred for a diagnostic ICA.
  • - Age above 35 years.

排除标准

  • - History of severe COPD or chronic asthma
  • - Pregnancy
  • - Renal failure (eGFR <30 mL/min)
  • - Use of sildenafil (Viagra) or dipyramidol (Persantin) that cannot be
  • - Contra-indications for β-blockers
  • - Allergic reaction to iodized contrast
  • - Concurrent or prior (within last 30 days) participation in other research
  • studies using investigational drugs
  • - Claustrophobia
  • - Significant co-morbidities
  • - Atrial fibrillation, second or third degree atrioventricular block
  • - Tachycardia
  • - Acute myocardial infarction (STEMI/NSTEMI)
  • - History of CABG
  • - Patients with a history of coronary chronic total occlusion
  • - LVEF estimated <50%
  • - Cardiomyopathies
  • - Previous radiation exposure in the diagnostic work-up
  • - Unable to give informed consent
  • - Indispensable follow-up with (serial) CT scans for non-cardiac related

研究者

相似试验

Defining the Diagnostic Value of High-Pitch CCTA and... | 临床试验